Interventions for central serous chorioretinopathy: a network meta-analysis

Project Summary Title and Description

Title
Interventions for central serous chorioretinopathy: a network meta-analysis
Description
The purpose of this form is to abstract data from reports corresponding to a study included in a systematic review.
Attribution
N/A
Authors of Report
N/A
Methodology description
Network meta-analysis
PROSPERO
N/A
DOI
10.26300/k2kf-7j83
Notes
Data retrospectively entered into SRDR for public accessibility.
Funding Source
National Eye Institute, National Institutes of Health

Key Questions

1. What is the comparative effectiveness of each interventions for central serous chorioretinopathy?

Associated Extraction Forms

Associated Studies (each link opens a new tab)

TitleAuthorsYear
Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial.
Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial.2014
Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial.
Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial.2008
Treatment of central serous chorioretinopathy with beta-blocker metipranolol.
Treatment of central serous chorioretinopathy with beta-blocker metipranolol.2015
Nadolol in the treatment of central serous retinopathy.
Nadolol in the treatment of central serous retinopathy.1993
Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy.
Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy.1983
Low fluence photodynamic therapy in chronic central serous chorioretinopathy: blind randomized clinical trial of efficacy and safety2008
Low fluence photodynamic therapy in chronic central serous chorioretinopathy: blind randomized clinical trial of efficacy and safety2008
The effect of eradicating Helicobacter pylori on idiopathic central serous chorioretinopathy patients.
The effect of eradicating Helicobacter pylori on idiopathic central serous chorioretinopathy patients.2013
Treatment of central serous chorioretinopathy with beta-blockers and calcium antagonists
Treatment of central serous chorioretinopathy with beta-blockers and calcium antagonists1994
Argon laser photocoagulation in the treatment of central serous retinopathy.
Argon laser photocoagulation in the treatment of central serous retinopathy.1979
Effects of propranolol in patients with central serous chorioretinopathy
Effects of propranolol in patients with central serous chorioretinopathy2008
Intravitreal ranibizumab for acute central serous chorioretinopathy.
Intravitreal ranibizumab for acute central serous chorioretinopathy.2013

Downloadable Data Content

Files
  • XLSX Project Data